Biocon Biologics Limited a subsidiary of Biocon Ltd announced that its subsidiary Biocon Sdn. Bhd. in Malaysia has been awarded a three-year contract, valued at USD 90 million* (MYR 375 million), for its recombinant human insulin brand Insugen®, by the Ministry of Health (MoH), Malaysia.
- Read more about Biocon Biologics gets USD 90 mn contract from Malaysia to supply insulin
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/biocon-biologics-gets-usd-90-mn-contract-from-malaysia-to-supply-insulin
No comments:
Post a Comment